Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06864273 · ClinicalTrials.gov registry record · NA

Assessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi Pharmacies

A NA study of Bilateral Hearing Loss and Health Services Research, sponsored by University of Alabama, Tuscaloo.

Recruiting
Registry status
NA
Development phase
144
Enrollment target
2
Study locations

NCT06864273 is a NA study of Bilateral Hearing Loss and Health Services Research that is actively recruiting participants, run by University of Alabama, Tuscaloo. The registered enrollment target is 144 participants, above the 34-participant average among 4 other Bilateral Hearing Loss trials with a reported enrollment target (324% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06864273, a NA study of Bilateral Hearing Loss and Health Services Research, is actively recruiting participants, sponsored by University of Alabama, Tuscaloo.

RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
2
Study locations

Study Summary

Hearing loss is a major public health concern due to its negative association with emotional well-being, cognition, and physical ailments, such as diabetes. Access to audiologists and otolaryngologists in many regions across the US is poor or extremely limited. Rural populations are older, less educated, and have lower household incomes compared to populations in metropolitan areas. Also, with increasing age adults experience greater rates of hearing loss. Fortunately, the 2022 FDA Final Rule for Over-the-Counter Hearing Aids (OTC HAs) could revolutionize assess to hearing aids and hearing healthcare by allowing adults with perceived mild-to-moderate hearing loss to purchase these devices over the counter, without medical clearance or care from an audiologist. Pharmacies located in rural areas now have the option to provide OTC HAs, something previously not possible. Currently, however, there are no established guidelines for effective provision of these devices in pharmacies located in rural communities. Educating pharmacy technicians to provide basic hearing healthcare related to OTC HAs use could address a critical need and create a new care delivery model to ensure sustainable, long-term access to hearing healthcare. The long-term goal of this study is to create a sustainable interprofessional collaborative between audiologists and pharmacists for the development of a hearing healthcare model that improves access and affordability of care in rural regions across the country. The specific aims are to 1) Determine an effective approach for educating pharmacy technicians for the provision of OTC HAs in rural community pharmacies, and 2) Identify satisfaction of care provided by pharmacy technicians and initial performance with OTC HAs in adults with hearing loss living in rural communities. A stepped wedged clinical trial design will be used to study the effectiveness of a comprehensive educational training program for pharmacy technicians. Technicians from rural A

Interventions

  • BEHAVIORAL Pharmacy Technician Educational Training

Study Locations (2)

Alabama

  • The Department of Communicative Disorders, Box 870242 - Tuscaloosa
  • The Department of Communicative Disorders - Tuscaloosa

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2025-07-25
Est. Completion 2026-08-31
Phase NA

Sponsor

University of Alabama, Tuscaloo

17 total trials

What the Registry Record Tells You About NCT06864273

The ClinicalTrials.gov registry entry for NCT06864273 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 34-participant average among 4 other Bilateral Hearing Loss trials with a reported enrollment target (324% higher). The listed sponsor is University of Alabama, Tuscaloo, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bilateral Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Pharmacy Technician Educational Training is the first listed.

NCT06864273 reports 2 study locations spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06864273 about?

NCT06864273 is a clinical study titled "Assessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi Pharmacies". Hearing loss is a major public health concern due to its negative association with emotional well-being, cognition, and physical ailments, such as diabetes. Access to audiologists and otolaryngologists in many regions across the US is poor or extremely limited. Rural populations are older, less educ...

What is the current status of trial NCT06864273?

This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2025-07-25. Estimated completion is 2026-08-31.

What conditions does trial NCT06864273 study?

This clinical trial studies the following conditions: Bilateral Hearing Loss, Health Services Research.

What interventions are being tested in trial NCT06864273?

The interventions under investigation include: Pharmacy Technician Educational Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06864273?

This trial is sponsored by University of Alabama, Tuscaloo, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06864273 being conducted?

This trial has 2 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bilateral Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.